3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Genitourinary
8
Breast
8
Gastrointestinal
7
Tumor-Agnostic
6
Thoracic
3
Lymphoid
3
Gynecologic
3
Other
2
Dermatologic
2
CNS
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Skin Neoplasms
1
Sezary Syndrome
1
Neoplastic Cells, Circulating
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Carcinoma, Merkel Cell
1
Interventions
Blood Specimen Collection
22
Surveys and Questionnaires
19
Nivolumab
14
Ipilimumab
12
pembrolizumab
11
Gene Expression Profiling
11
Biopsy
10
trametinib
9
dabrafenib
8
Flow Cytometry
8
Specimen Handling
7
Polymerase Chain Reaction
7
Tomography, Optical Coherence
6
Therapeutics
6
Immunohistochemistry
6
Imiquimod
6
Amplified Fragment Length Polymorphism Analysis
6
Watchful Waiting
5
Psychiatric Rehabilitation
5
Immunotherapy
5
Data Collection
5
3-ingenyl angelate
5
Mohs Surgery
4
Microarray Analysis
4
Interviews as Topic
4
Immunoenzyme Techniques
4
Drug Therapy
4
Dermoscopy
4
sonidegib
3
encorafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Hematologic Tests
×
Dermatologic
×
Clear all
NCT04904146
2025-03-10
BIO-MUSE
Lund University Hospital
Recruiting
120 enrolled
NCT06448611
2024-06-13
MERCCALIBI
University Hospital, Montpellier
Not yet recruiting
25 enrolled